Acetylcysteine Injection
Product Images NDC 0574-0805

3 FDA label images from Padagis Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 0574-0805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Revised Rumack-matthew Nomogram For Estimating Risk Of Hepatoxicity After Acute Ingestion Of Acetaminophen (Figure 1)

Figure 1. Revised Rumack-matthew Nomogram For Estimating Risk Of Hepatoxicity After Acute Ingestion Of Acetaminophen (Figure 1)
Chart depicting acetaminophen blood concentration (µg/mL) versus time since ingestion (hours). It shows two key lines: a high-risk line in a shaded area above a treatment line, illustrating risk and treatment thresholds over a 24-hour period post-ingestion.*
FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure diagram of acetylcysteine, showing molecular components including amino, carboxyl, methyl, and thiol groups as connected by lines representing chemical bonds.*
FDA Label Image

Acetylcysteine Injection 6 G/30 mL Carton (33u C2)

Acetylcysteine Injection 6 G/30 mL Carton (33u C2)
Packaging label for Acetylcysteine Injection 6 g/30 mL (200 mg/mL) from Padagis US LLC. The label indicates the product is for intravenous use, requires further dilution prior to administration, and comes in 4 x 30 mL sterile vials. The label includes storage instructions, preservative information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.